Latest Parker Waichman LLP Stories
New York City Council members have joined efforts to reauthorize the Zadroga Act, which provides compensation and medical treatment funds to first responders and rescue workers injured due to
The litigation brought over the Johnson & Johnson subsidiary’s all-metal hip device continues to proceed with an Order for an open court conference. Port
Use of power morcellation devices during some minimally invasive gynecological procedures has been associated with increased risks of spreading hidden cancers, in some cases, months following
The fine is the largest, to date, levied against an automaker by federal regulators and is the maximum allowable fine allowed to be levied by federal regulators. Port
As off-label antipsychotic use is mounting so, too, is litigation associated with specific atypical antipsychotics Port Washington, New York (PRWEB) January
A class action lawsuit alleges that T.G.I.
The case involved alleged fraudulent activities involving Hurricane Katrina claim activity, including directing the National Flood Insurance Program to pay benefits covered under an insured’s
According to a research scientist at MIT, there is a correlation between autism rates and the use of Monsanto's Roundup herbicide.
The first status conference in the federal multidistrict litigation over Xarelto's bleeding risks is scheduled for January 29, 2015 in the Eastern District of Louisiana.
In the new year, Parker Waichman hopes for increased testing, safety, and efficacy in the processes and promotions used by Big Pharma so that consumers may be confident that they are receiving
- To fire mitraille at.